510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Stanbio Laboratory Hemopoint H2 Hemoglobin Measurement System

K081719510(k) SpecialCleared Jul 18, 200830-day reviewClass II21 CFR 864.5620Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Stanbio Laboratory · GKR System, Hemoglobin, Automated

Cleared on Jul 18, 2008 after a 30-day review. The FDA summary names its predicate without a number. 2 later devices descend from it. It has been recalled once.

Decided
Jul 18, 2008
Review
30 days
Class
Class II
Product code
GKR
Recalls
1
Predicates
0

2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2011: 1 descendant cleared2018: 1 descendant cleared20052010201520202025
  1. This deviceK081719 Stanbio Laboratory Hemopoint H2 Hemoglobin Measurement SystemStanbio Laboratory · 2008
  2. Descendant · cites it directly · 0 of its ownK172173 DiaSpect Tm, DiaSpect Tm CuvettesEkf-Diagnostic GmbH · 2018
  3. Descendant · cites it directly · 0 of its ownK110393 Ekf- Diagnostic Hemo_Control Hemoglobin Measurement System…Ekf-Diagnostic GmbH · 2011

Most influential descendants

Showing 2 of 2 · See all
  • K172173DiaSpect Tm, DiaSpect Tm CuvettesEkf-Diagnostic GmbH · 2018 · cites it directly0descendants
  • K110393Ekf- Diagnostic Hemo_Control Hemoglobin Measurement System; Ekf-Diagnostic Hemoglobin…Ekf-Diagnostic GmbH · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K081719Stanbio Laboratory Hemopoint H2 Hemoglobin Measurement SystemStanbio Laboratory2008—
+1K172173DiaSpect Tm, DiaSpect Tm CuvettesEkf-Diagnostic GmbH2018—
+1K110393Ekf- Diagnostic Hemo_Control Hemoglobin Measurement System; Ekf-Diagnostic…Ekf-Diagnostic GmbH2011—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201810
FIG. 1 — Lineage of K081719, 2008–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKR device

  1. #1 K201217 HemoCue Hb 301 Systemscore 0.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—HemoPoint® H2 Hemoglobin Measurement System with microcuvette
Named without a submission number
—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172173DiaSpect Tm, DiaSpect Tm CuvettesEkf-Diagnostic GmbH20180
K110393Ekf- Diagnostic Hemo_Control Hemoglobin Measurement System; Ekf-Diagnostic Hemoglobin…Ekf-Diagnostic GmbH20110

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 8, 2018Class IIZ-2926-2018Nonconforming Material/ComponentThe US prong (type A) adapter plate may crack, break, or detach and remain in the electrical outlet exposing live electrical contacts.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K172173 (Ekf-Diagnostic GmbH, 2018) has gone furthest, with 0 descendants of its own.

How does its category compare?

All GKR devices

GKR System, Hemoglobin, Automated: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · GKR

2in 2020

2008: 12009: 12011: 12013: 22017: 12018: 22019: 12020: 2
2007high 2 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKR

Too few GKR 510(k)s in any year since 2007 to give a median.

Recalls per year · GKR

1in 2013

2010: 12011: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GKR

1in 2024

2008: 22009: 162010: 92011: 122012: 252013: 432014: 312015: 192016: 92019: 92020: 12021: 12022: 12024: 1
2007high 43 (2013) · low 0 (2007)2025

MAUDE reports naming product code GKR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—02
20091—016
20100—19
20111—112
20120—025
20132—143
20140—031
20150—019
20160—09
20171—00
20182—00
20191—09
20202—01
20210—01
20220—01
20230—00
20240—01
20250—00
20260—0—

What is it indicated for?

The HemoPoint ® H2 Hemoglobin Measurement System is indicated for the quantitative determination of hemoglobin in arterial, venous, or capillary blood. The microcuvettes part number 3010-100 are indicated for use in the HemoPoint ® H2 Hemoglobin Measurement System and the Hemocue® measurement system. The microcuvettes are intended to be used only once and must be disposed of after use as potentially infectious waste. Estimation of hematocrit as a…

Read the full statement (111 words)

The HemoPoint ® H2 Hemoglobin Measurement System is indicated for the quantitative determination of hemoglobin in arterial, venous, or capillary blood.

The microcuvettes part number 3010-100 are indicated for use in the HemoPoint ® H2 Hemoglobin Measurement System and the Hemocue® measurement system. The microcuvettes are intended to be used only once and must be disposed of after use as potentially infectious waste.

Estimation of hematocrit as a function of Hemoglobin is performed for normal hemoglobin ranges only (120 to 180 g/liter or 12.0 to 18.0 g/deciliter). The estimated hematocrit is not indicative of disease states such as anemia and abnormal values will not be reported.

For InVitro Diagnostic Use Only

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081719: Stanbio Laboratory Hemopoint H2 Hemoglobin Measurement System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K081719

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026